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Mitochondrial gene mutation plays a role in the development of type two diabetes mellitus (T2DM). A point 
mutation in the mitochondrial gene Nicotinamide adenine dinucleotide dehydrogenase 1 (mtDNA ND1) gene mainly 
reported as the most common mutation related to T2DM. However, several studies have identified another SNP (single-
nucleotide polymorphisms) in the RNA region of mtDNA from patients from specific ethnic populations in Indonesia. 
Building on those findings, this study aimed to use PCR and DNA sequencing technology to identify nucleotides in 
RNA and ND1 fragment from 20 Gorontalonese and 20 Javanese T2DM patients, that may trigger T2DM expression. 
The results showed successful amplification of RNA along 294 bp for all samples. From these samples, we found two 
types of point  mutation in Javanese patients in the G3316A and  T3200C points of the rRNA and ND1 gene. In samples 
taken from Gorontalonese patients, no mutation were found in the RNA or ND1 region. We conclude that T2DM was 
triggered differently in our two populations. While genetic mutation is implicated for the 20 Javanese patients, T2DM 
pathogenesis in the Gorontalonese patients must be traced to other genetic, environmental, or behavioral factors.
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INTRODUCTION
 Type 2 Diabetes Mellitus (T2DM) is a chronic 
disease of metabolic disorder caused by insulin 
resistance in target membranes (Lim et al. 2011). 
In Asia, Indonesia  reports the highest number of 
T2DM patients (Ibrahim et al. 2010). An increase in 
the incidence of T2DM is predicted throughout the 
world, from 285 million cases in 2010 to 439 million 
in 2030 (Shaw et al. 2009).
 The pathogenesis of T2DM is influenced by 
several factors including environment, food and 
genetics factors. Genetic factors are explored 
in much of the current research, which conduct 
molecular studies of the DNA of T2DM patients. 
T2DM has been traced in some patients to mutations 
in mitochondrial DNA (mtDNA). Puspitaningrum 
et al. (2014a) tried to identify nucleotide sequence 
variation in the hypervariable region of 1D-Loop 
mtDNA, in T2DM patients and their offspring, 
theorizing that mutations in this region may be 
precipitating cause of diabetes.
 Mitochondrial DNA is circular double chain 
DNA 16.569 base pairs long, that encompasses 2 
rRNA genes, 22 tRNA genes and 13 subunit protein 
genes for a complex respiration chain (Alexeyev et 
al. 2004). The mtDNA mutation most commonly 
linked by research to T2DM is found in tRNA-leu, 
at site 3243 (Zhong et al. 2000; Poulton et al. 2002). 
However, Puspitaningrum et al. (2014) did not 
find this mutation or any others in the tRNA of 20 
Javanese T2DM patients studied.
 The risk of T2DM is depends greatly on the 
population under consideration; in general diabetes 
risk is 1 to 5%; however, it is 6 to 7% in the US 
with even higher risk if the patient has one or more 
affected siblings (Nussbaum et al. 2007). Therefore, 
it is important to study the prevalence of T2DM in 
specific population, and in particular to determine 
whether there are genetic factors that contribute to 
pathogenesis of T2DM. Genetic factors have been 
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traced along some ethnics lineages in Indonesia, 
including the Gorontalonese ethnic.
 The Gorontalonese population lives in the 
northern part of Sulawesi Island, generally enjoying 
an intact natural environment and traditional diet. 
But, city hospital have reported a marked increase in 
the prevalence of T2DM since 2006, in pace with the 
development of Gorontalo City. This study using 20 
Gorontalonese patients as one of two subjects group 
of interest, whose DNA is examined for evidence of 
a potential genetic basis for acquiring T2DM.
 In Indonesia, the Javanese ethnic also shows 
relatively higher rates of T2DM. There are 57.7% 
more Javanese T2DM patients than there are 
Minangnese, Manadonese, and Torajanese patients. 
Moreover, the incidence of T2DM among the 
Javanese is rising, from 0.83% in 2006 to 0.96% 
in 2007 and 1.25% in 2008 (Central Java Province 
Health Services 2008). In 2007, Wates Hospital in 
Yogyakarta Province treated 124 T2DM patients per 
month; and in 2012 the hospital saw an average of 
160 patients of T2DM per month. Despite the fact 
that Javanese are disproportionately afflicted with 
T2DM, molecular genetic research on Javanese 
patients has not yet been undertaken. We therefore 
selected Javanese patients as the second ethnic group 
of enquiry for our investigation of genetic mutations 
in RNA and in ND1 region.
 Analysis of RNA and ND1 genes was conducted 
by a technique of sequencing PCR products. Genetic 
sequences obtained from this process can serve as a 
reference for further research. The framework of our 
research rests on prior studies that found variation—
due to mutation—in the RNA and ND1 sequences of 
T2DM patients. We sought evidence of the same or 
similar variation in the DNA of our study subjects. 
Our subjects were 20 Javanese T2DM patients at 
Wates Hospital, Yogyakarta; and 20 Gorontalonese 
patients from Aloei Saboe Gorontalo City Hospital. 
The sequences that we identify can also be used as 
a references for genetic research regarding T2DM 
patients of other ethnic background in Indonesia.
MATERIALS AND METHODS
 The protocol for this research has been approved 
by the Ethics Committee University of Indonesia 
document number 532/PT02.FK/ETIK/2012. Our 
research subjects included one group of 20 T2DM 
patients from Aloei Saboe Gorontalo City Hospital, 
and another group of 20 T2DM patients from Wates 
Hospital, Yogyakarta. Subjects ranged in age from 
35 to 60 years old. DNA samples were taken from 
each subjects, and secondary data was collected about 
diet, family clinical background, and daily activities.
 DNA extraction and PCR replication took place in 
the Biochemistry and Molecular Biology Laboratory, 
Biology Department, Faculty of Mathematics 
and Natural Science, Universitas Negeri Jakarta, 
Indonesia. DNA sequencing analysis was carried out 
in the Laboratory of Clinical Technology, Faculty 
of Health Science, Yamaguchi University School of 
Medicine, Japan.
 Blood Sampling and DNA Extraction. The 
blood taken from the subjects in each hospital 
were saved in refrigerator until the DNA extraction 
process. Mitochondrial DNA was extracted from 3 
mL of whole blood using a PROMEGA Extraction 
Kit® for whole blood with several modifications. 
Modifications included the use of isopropyl alcohol 
to take the DNA from the blood cells. The extracted 
DNA samples were stored at -20 oC before analysis.
 Polymerase Chain Reaction (PCR). PCR was 
used for amplification of the RNA and ND1 region 
located on mtDNA. PROMEGA Master Mix® for 
PCR was used with a primer of Mt3243 forward 
5’-AGG ACA AGA GAA ATA AGG CCT-3’ and 
Mt3243 reverse 5’-AAC GTT GGG GCC TTT GCG 
T-3’. PCR products of RNA and ND1 region with 
294 bp size only, were carried out in a total volume 
of 50 μL. The DNA was first denaturized at 94 oC 
for 3 min and then subjected to 30 PCR cycles at: 94 
oC for 30 sec, 60 oC for 30 sec, and 72 oC for 30 sec. 
Amplified products were confirmed via 2% agarose 
gel electrophoresis.
 Sequencing. Approximately, 2 μL of purified PCR 
product--purified using the protocol by Qiagen®--
was amplified in a total reaction volume of 20 μL 
containing the Big Dye terminator reaction buffer, 
each of the primers, and molecular grade water. The 
amplified gene was precipitated after several alcohol 
washes at 95 and 70%, dried in a vacuum centrifuge, 
resuspended in Hi-Di formamide and loaded into ABI 
3130xl Sequence Analyzer (Applied Biosystems) 
for sequencing. Sequence editing and analysis was 
conducted using Sequencher® 5.0.1. software for 
Macintosh®.
RESULTS
 Fragments of RNA Genes as Amplified with 
PCR Technique. The amplified area of reverse and 
forward primer mt3243 is shown in Figure 1. The 
blue nucleotide sequence shows the coding area of 
16S rRNA, while the red one shows the coding area 
of tRNA Leucine. The black sequence is the gene 
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and ND1 mutation, i.e. Mitochondrial Myopathy, 
Encephalopathy, Lactic Acidosis, and Stroke Like 
Episodes (MELAS).
Figure 1. Nucleotide sequence of 16S rRNA, tRNALeucine and ND1 genes amplified by mt3243 reverse and forward primers. 
Blue: coding area of 16S rRNA gene, red: coding area of tRNALeucine gene, black: coding area of ND1 gene (Gene 
Bank NCBI, 2012).
ND1 area. Figure 2 shows a visualization of the RNA 
gene fragment produced during PCR. The resulting 
sequences were compared to the data base of human 
mitochondrial DNA using BLAST (Basic Local 
Alignment Search Tools) online on DDBJ (DNA 
Data Bank of Japan).
 Mutation of T3200C and G3316A mtDNA in 
T2DM Javanese Patients. The sequencing data that 
we obtained revealed two mutations, in two Javanese 
T2DM patients. One mutation was to T3200C located 
in the 16S rRNA region. The arrow illustrates a 
base change from T to C (Figure 3). This mutation 
occurred in sample P16 from a T2DM patient. Figure 
4 illustrates the second point mutation to G3316A 
on site 3316 in ND1 region. The arrow indicates a 
base change from G to A. There was no mutation or 
any base change detected in the tRNA of any of the 
subjects.
 Type 2 Diabetes Mellitus in Gorontalonese 
Patients. The sequencing results of RNA and ND1 
regions for all of the T2DM and control samples 
revealed no SNP. This result is in line with the 
clinical profiles of the subjects, none of whom 
had Maternally Inherited and Diabetes (MIDD) or 
exhibited symptoms known to be related to RNA 
Figure 3. T3200C mutation in sample P16 occurs in site 3200 
on gene 16 rRNA mtDNA. Mutation point shows a 
base change from T to C.
Figure 4. Mutation of G3316A from sample P10 in site 3316 
on gene ND1 mtDNA. Mutation point shows a base 
change from G to A.
                   M      2      4       6       8      10     12    14     16     18     20
1500 bp
294 bp
1000 bp
500 bp
300 bp
200 bp
100 bp
Figure 2. Visualization of PCR products of P1-P20 samples 
through electrophoresis of 2% agarose gel shows 
294 bp bands. M: Marker of 100 bp DNA Ladder; 
1-20: PCR products of tRNA gene fragments in 
T2DM patients samples of Javanese tribe.
                   M  1      3       5      7        9      11    13     15    17     19 
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DISCUSSION
 T2DM Javanese Patients. Common symptoms 
of T2DM include fatigue, increased hunger and thirst, 
and frequent urination; 90% of the subjects in this 
study is also having obesity. Obesity may be caused 
by polyphagia and the type of metabolic syndromes 
experienced by T2DM patients (Sherwood 2010). 
Twenty percent of the research subjects had a family 
history of T2DM, which support evidence from prior 
studies of a genetic basis for diabetes (Codario 2005). 
 The use of oral medication by patients in this 
research showed 20% of Metformin users and 10% 
of Glimpiride users. While Glimepiride is an oral 
medication which can control blood sugar (Kanazawa 
et al. 2009; Ahad et al. 2011), as many as 75% of 
patients checked their blood sugar periodically. 
Periodical checks of blood sugar helps patients 
understand and be aware of their blood sugar level. 
This is necessary to keep their body in good shape. 
 A total of 65% patients said they kept a healthy 
diet, such as three tablespoons of rice (carbohydrate) 
in each meal. This can reduce the level of blood 
sugar. There were 15% of patients who regularly 
exercised for more than 30 min and the rest exercised 
only less than that. Thirty-minutes daily exercise is 
recommended by International Diabetes Federation 
(Haque et al. 2011). All subjects in this research, 
patients and non-patients, are of Javanese tribe. This 
was a necessary criterion as the research aimed to 
trace the genetic factors that caused T2DM in people 
of Javanese ancestry.
 The Base Nucleotide Fragments of RNA and 
ND1 Gene Fragments in 20 T2DM Javanese 
Patients. All the samples taken from Javanese 
subjects—20 T2DM and five non-patients—were 
successfully matched using homolog analysis. 
Results showed that all samples analyzed were 100% 
identical in sequence to human mtDNA data in the 
Gene Bank (Figure 4). The two point mutations 
discovered during molecular analysis were located 
at gene site of 16S rRNA and in the ND1 fragment. 
 One mutation discovered was a T3200C mutation 
(Figure 4) in sample P16 from a T2DM patient. The 
T3200C mutation involved a base change from T to 
C on site 3200 gene 16S rRNA. A mutation in this 
gene affects ribosome generation and is implicated 
in the increased number of ribosomes found in 
T2DM patients. Nucleotide substitution from T to C 
results in abnormal change to the shape of ribosome, 
indicative of a disease (Tao et al. 2002). Previous 
researches on RNA mutation in T2DM patients also 
found mutations in gene 16S rRNA and ND1. The 
mutations were found to be associated with the trigger 
of T2DM (Pranoto 2005).
 Our research revealed a second mutation, of 
G3316A in sample P10 from a subject with T2DM. 
This was a point mutation that occurred in gene ND1, 
and was located on site 3316, involving a base change 
from G to A. This mutation affects the coded subunit 
1 NADH dehydrogenase, a component of OXPHOS 
complex 1 in mitochondria. The mutation may affect 
enzyme activities of NADH dehydrogenase so it 
might cause T2DM (Pranoto 2005).
 Absence of Mutation in RNA and ND1 in T2DM 
Gorontalonese Patients. The A3243G mutation—
the most common mutation in tRNA region related 
to T2DM (Porte & Sherwin 1997)—did not appear 
in 20 T2DM subjects and 20 normal controls. The 
A3243G mutation has been previously found in 
T2DM patients in populations from Japan (Katagiri 
et al. 1994; Ohkubo et al. 2001; Yorifuji et al. 2012); 
Egypt (Fawzi et al. 2006); Finland (Majamaa et al. 
1998); among the Chinese Han population (Liao et al. 
2008); and many more. However, other investigators 
have failed to find this A3243G mutation. Rigoli et al. 
(1997) did not detect any A3243G mutation among 
231 T2DM patients from Southern Italy. Naveed et 
al. (2009) also had negative result when testing for 
the A3243G mutation among 39 T2DM Pakistani 
patients as well as 129 MIDD Polish patients (Ma et 
al. 2001), 10 Tamil Indian patients (Lepretre et al. 
1998), and 112 T2DM Nigerian patients (Ameh et 
al. 2011).
 Absence of mutation in our samples from 20 
T2DM Gorontalonese was probably due to several 
factors. Firstly, it may be that the sample size was 
too small. Previous investigations have discovered 
the A3243G mutation in only a very small proportion 
of the sample tested. Ohkubo et al. (2001) found that 
only 2.9% of the A3243G mutation from 240 T2DM 
patients had the A3243G mutation in a Japanese 
study. Kunsan et al. (1997) found that 0.5% of 207 
T2DM Chinese patients had the mutation, and a 
study of 100,000 T2DM patients worldwide found 
only 5.71% with the A3243G mutation (Maasen & 
Kadokawi 1996). Meanwhile Gerbitz et al. (1995)
estimated that the prevalence of this mutation is 
approximately 1.5% of the diabetic population 
worldwide.
 Secondly, none of the T2DM patients in our study 
exhibit severe clinical characteristics, such as acute 
deafness, obesity, and stroke-like syndrome, that are 
often seen in MIDD and MELAS patient (Porte & 
Sherwin  1997; Zhong et al. 2000; Chen et al. 2004; 
Kanaumi et al. 2006). Previous studies have linked 
Vol. 21, 2014                                                                  Mutation of mtDNA Gene T2DM of Gorontalonese and Javanese       163
the A3243G mutation to MIDD and MELAS (Onishi 
et al. 1993; Porte & Sherwin 1997; Solano et al. 2000; 
Shanske et al. 2004). Patients from our study were 
only exhibit more general symptoms of T2DM such 
as mild obesity, fatigue and increase appetite (Porte 
& Sherwin 1997).
 Thirdly, previous investigations have reported 
that DNA taken from leucocytes had the lowest 
incidence of the tRNA A3243G mutation compared 
to DNA taken from skeletal muscle (Kelley et al. 
2002), urinary sediment (Solano et al. 2000), skin 
fibroblast, hair roots, and cheek mucosa (Shanske 
et al. 2004). Other research suggest that A3243G 
mutation are less prevalent in blood DNA taken from 
the elderly because heteroplasmy levels of mutant 
mtDNA decrease in leucocytes upon aging (Hart et 
al. 1996; Sue et al. 1998). For the reasons above, we 
cannot state with certainly that the Gorontalonese 
T2DM patients in this study do not possess the tRNA 
A3243G mutation. Further investigation of DNA 
from other tissues is needed to get more conclusive 
data.
 Alternative Causes of T2DM Prevalence in 
Gorontalonese. Prevalence of T2DM varies from 
population to population (Zimmet 1992). Many risk 
factors have been identified which influence the 
prevalence or incidence of T2DM, such as family 
history of T2DM, age, excess weight, increased 
abdominal fat, hypertension, lack of physical 
exercise, and ethnic background (van Tilburg et 
al. 2001). Many prior investigations have also 
demonstrated that lifestyle factors can function as 
an initiator of mutation in T2DM (Kahn et al. 1996; 
So et al. 2000; Watanabe et al. 2007).
 Hospital record in Gorontalo shows that both the 
prevalence and incidence of T2DM in the city has 
increase about 15% per year since 2006. This might 
be linked to changes in socio-economic status, as 
Gorontalo City urbanized, and as rural citizens move 
to the city. As mentioned earlier, environment and 
lifestyle play an important role in the development 
of T2DM (Mohan et al. 2005). Changes in the 
socio-economic status of Gorontalo City residents 
(the capital city of Gorontalo Province) began to be 
felt in 2005. Gorontalo Province is recently formed 
jurisdictions that split off from the province of North 
Sulawesi in 2001. As capital of the new province, 
Gorontalo City experienced rapid development 
beginning in 2003. Growth resulted in an abundance 
of newly-build convenient stores, lifestyle center, 
modern market, malls, and fast food restaurants that 
changed the character of the city and the behavior 
of residents. Increased city development aligned 
increase in the prevalence of T2DM reported by 
hospitals. In 2006 the average number of T2DM in 
the city was one thousand per year, up from 500 cases 
reported one year earlier in 2005. In 2012, the average 
number of T2DM reaching two thousand cases per 
year or four times higher than in 2006.
 A similar correlation between T2DM incidence 
and rapid development has been described in India 
where prevalence of T2DM is only about 3% in 
rural areas (Ramachandran 2002) while in urbanized 
cities it approaches 16% (Raman et al. 1999). This 
large divergence in the prevalence of T2DM in 
rural vs. urban populations is probably a result of 
environmental and behavioral factors. The prevalence 
of T2DM also follows another demographic trend, 
increasing as ethnic groups migrate from the world’s 
less developed regions to urban region or westernized 
regions (van Tilburg et al. 2001). As an illustration, 
the T2DM in ethnic Japanese residents in Hawaii 
was found to be higher than in Japan (Fujimoto et 
al. 1991) and the prevalence of T2DM in ethnic 
Chinese residents in Mauritius was 13% higher than 
in mainland China (Fujimoto 2000).
 These previous findings are corroborated by the 
findings in our study. Almost all the T2DM subjects 
acknowledged heavy consumption of food and 
beverages that are high in trans-fats and/or have 
a high Glycemic Index (GI), without significant 
physical activity. Unsurprisingly, most of the diabetic 
subjects were obese, in contrast to the control subjects 
who maintained normal weight, and practiced 
healthier eating and fitness. Studies have identified 
several protective behaviors that can reduce the 
incidence of T2DM in women by as much as 90%. 
These include: maintaining a body-mass index of 25 
or lower, eating a diet high in cereal fiber and poly-
unsaturated fat and low in saturated and trans-fats and 
in glycemic load; regular exercise, abstaining form 
smoking, and moderate alcohol consumption (Hu 
et al. 2001). Such findings suggest that the majority 
of cases of T2DM could be prevented by weight 
loss, regular exercise, modification of diet, smoking 
cessation, and limited alcohol consumption. Weight 
control appears to offer the greatest benefit.
 The result of our genetic research and analysis of 
samples from Javanese T2DM patients and control 
subjects, revealed a mutation in the mtDNA ND1 
gene. No variation or mutation was found in the tRNA 
genes of this group. Two mutations were also found 
in T2DM patients, T3200C in gene 16S rRNA and 
G3316A in gene ND1 which were related to T2DM. 
T2DM patients samples did not have any mutation 
in tRNA gene, 16S rRNA, and ND1, which was 
probably cause by lack of exercise and unhealthy 
diet. 
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 Meanwhile in Gorontalonese subjects, we did not 
find any mutations. The high prevalence of T2DM 
among the Gorontalonese ethnic could probably 
caused by another genetic, environmental, and/or 
lifestyle factors. From both ethnics, we conclude that 
there is different expression of T2DM among both 
ethnicity due to different genetic, environmental, and 
lifestyle trigger.  
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